The ChatGPT maker is folding Orchestra’s drug-program agents into Rosalind, its life sciences suite, betting AI can shave time off the decade-plus it takes to bring a medicine to patients.
Read the full article at the source.
crypto
from Decrypt
OpenAI Buys Orchestra Bio to Put AI Agents in Charge of Drug Development Grunt Work
Jose Antonio Lanz
3 hours ago
3 Views
0 Comments
Join the discussion — comment, vote, and submit links.
Register
Comments (0)
No comments yet. Be the first to comment!